Report cover image

Insulin Glargine Market, By Type (Lantus, Basaglar, Toujeo, Soliqua/Suliqua, Others), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, La

Publisher Coherent Market Insights
Published Feb 20, 2025
Length 167 Pages
SKU # CMI19682360

Description

Global insulin glargine market is estimated to be valued at USD 5.81 Bn in 2025 and is expected to exhibit a CAGR of 6.6% during the forecast period (2025-2032). Insulin glargine, also known as Lantus, is a long-acting basal insulin that is used for the treatment of diabetes mellitus. It is a synthetic form of human insulin created through recombinant DNA technology, engineered to be soluble in acidic environments. Upon injection, it precipitates and forms microcrystals in the subcutaneous tissue, creating a depot from which insulin is gradually absorbed into the bloodstream. This extended release and duration of action profile allows once-daily dosing to help control blood glucose levels in patients with type 1 and type 2 diabetes over 24 hours. Insulin glargine has a slower absorption profile as compared to other basal insulins such as insulin detemir and insulin NPH, and thus, provides a smooth and consistent level of insulin in the blood.

Market Dynamics:

Global insulin glargine market growth is driven by growing prevalence of diabetes worldwide. According to estimates by the International Diabetes Federation 2021, over 537 million adults lived with diabetes in 2021, and the number is projected to rise to 643 million by 2030 and 783 million by 2045. Increasing geriatric population also contributes to market growth since diabetes is more common in older age groups. However, cost constraints, especially in developing countries, acts as a restrain. On the positive side, ongoing development of more effective and convenient drug delivery technologies is expected to present new opportunities.

Key Features of the Study:
  • This report provides in-depth analysis of the global insulin glargine market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global insulin glargine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Sanofi, Biocon, Eli Lilly and Company, Boehringer Ingelheim, Gan & Lee, Kalbe Pharma, Polus Biopharm, Samsung Bioepis, Wockhardt, Novo Nordisk AS, Julphar, and Viatris Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global insulin glargine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insulin glargine market.
Detailed Segmentation
  • Type:
  • Lantus
  • Basaglar
  • Toujeo
  • Soliqua/Suliqua
  • Others
  • Diabetes Type:
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Company Profiles:
  • Sanofi
  • Biocon
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Gan & Lee
  • Kalbe Pharma
  • Polus Biopharm
  • Samsung Bioepis
  • Wockhardt
  • Novo Nordisk AS
  • Julphar
  • Viatris Inc.

Table of Contents

167 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Diabetes Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of diabetes worldwide
High cost of insulin glargine
Increase in awareness about diabetes management
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Insulin Glargine Market– Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Insulin Glargine Market, By Type, 2020-2032, (USD BN)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Lantus
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Basaglar
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Toujeo
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Soliqua/Suliqua
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
6. Global Insulin Glargine Market, By Diabetes Type, 2020-2032, (USD BN)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Type 2 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Type 1 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
7. Global Insulin Glargine Market, By Distribution Channel, 2020-2032, (USD BN)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
8. Global Insulin Glargine Market, By Region, 2020-2032, (USD BN)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
North America
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD BN)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD BN)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD BN)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Biocon
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Gan & Lee
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kalbe Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Polus Biopharm
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Samsung Bioepis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Wockhardt
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novo Nordisk AS
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Julphar
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Viatris Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst View
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 24 market data tables and 28 figures on Global Insulin Glargine Market” –forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us